ANIP vs SNY
ANI Pharmaceuticals Inc (ANIP) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
SNY (SNY) common stock.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
SNY does not have a complete income-statement cache yet.
ANIP currently screens at market cap $1.41B. SNY currently screens at market cap $0.
Not investment advice. Open the ANIP and SNY stock pages for the full models.
Not investment advice.